This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Frank Xu
Vice President and Co-founder at Vazyme Biotech
Speaker

Profile

Dr. Xu is the co-founder and the vice president of Vazyme biotech Co., Ltd. He has been working in the life science industry for over 15 years. He and his team pioneered the development and marketing of numerous life science product lines, including molecular biology reagents and library preparation reagents for NGS. Dr. Xu also has extensive experience in business strategy and product management. Dr. Xu is currently responsible for the biomedicine business unit at Vazyme, which dedicates to deliver the state-of-the-art assay reagents for drug discovery and development and engineered enzymes for the manufacturing of nucleic acid-based medicines.

Agenda Sessions

  • Innovation in Assays and Enzymes of RNA Therapeutics Development

    7:45am